My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1632

    1.

    Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.

    Basu R, Shah P, Basu A, Norby B, Dicke B, Chandramouli V, Cohen O, Landau BR, Rizza RA.

    Diabetes. 2008 Jan;57(1):24-31. Epub 2007 Oct 3.PMID: 17914032 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes.

    Basu R, Basu A, Chandramouli V, Norby B, Dicke B, Shah P, Cohen O, Landau BR, Rizza RA.

    Diabetologia. 2008 Nov;51(11):2031-40. Epub 2008 Sep 4.PMID: 18769904 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.

    Miyazaki Y, Mahankali A, Matsuda M, Glass L, Mahankali S, Ferrannini E, Cusi K, Mandarino LJ, DeFronzo RA.

    Diabetes Care. 2001 Apr;24(4):710-9.PMID: 11315836 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes.

    Iozzo P, Hallsten K, Oikonen V, Virtanen KA, Parkkola R, Kemppainen J, Solin O, Lonnqvist F, Ferrannini E, Knuuti J, Nuutila P.

    Diabetes Care. 2003 Jul;26(7):2069-74.PMID: 12832315 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake.

    Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, Rizza RA.

    Diabetes. 1998 Nov;47(11):1735-47.PMID: 9792543 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog.

    Sindelar DK, Balcom JH, Chu CA, Neal DW, Cherrington AD.

    Diabetes. 1996 Nov;45(11):1594-604.PMID: 8866566 [PubMed - indexed for MEDLINE]Related articles

    7.

    Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.

    Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA.

    Diabetes. 2003 Jun;52(6):1364-70.PMID: 12765945 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The effect of pioglitazone on hepatic glucose uptake measured with indirect and direct methods in alloxan-induced diabetic dogs.

    Matsuhisa M, Shi ZQ, Wan C, Lekas M, Rodgers CD, Giacca A, Kawamori R, Vranic M.

    Diabetes. 1997 Feb;46(2):224-31.PMID: 9000698 [PubMed - indexed for MEDLINE]Related articles

    9.

    Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.

    Cusi K, Consoli A, DeFronzo RA.

    J Clin Endocrinol Metab. 1996 Nov;81(11):4059-67.PMID: 8923861 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production.

    Wise S, Nielsen M, Rizza R.

    J Clin Endocrinol Metab. 1997 Jun;82(6):1828-33.PMID: 9177391 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance.

    Dorella M, Giusto M, Da Tos V, Campagnolo M, Palatini P, Rossi G, Ceolotto G, Felice M, Semplicini A, Del Prato S.

    J Clin Endocrinol Metab. 1996 Apr;81(4):1568-74.PMID: 8636369 [PubMed - indexed for MEDLINE]Related articles

    12.

    Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Jan;89(1):200-6.PMID: 14715850 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Free fatty acid kinetics during long-term treatment with pioglitazone added to sulfonylurea or metformin in Type 2 diabetes.

    Roden M, Mariz S, Brazzale AR, Pacini G.

    J Intern Med. 2009 Apr;265(4):476-87.PMID: 19298459 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes.

    Gastaldelli A, Casolaro A, Pettiti M, Nannipieri M, Ciociaro D, Frascerra S, Buzzigoli E, Baldi S, Mari A, Ferrannini E.

    Clin Pharmacol Ther. 2007 Feb;81(2):205-12.PMID: 17259945 [PubMed - indexed for MEDLINE]Related articles

    15.

    Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes.

    Lewis GF, Carpentier A, Vranic M, Giacca A.

    Diabetes. 1999 Mar;48(3):570-6.PMID: 10078558 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.

    Basu R, Basu A, Nielsen M, Shah P, Rizza RA.

    J Clin Endocrinol Metab. 1999 Jul;84(7):2314-9.PMID: 10404795 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The effect of pioglitazone on the liver: role of adiponectin.

    Gastaldelli A, Miyazaki Y, Mahankali A, Berria R, Pettiti M, Buzzigoli E, Ferrannini E, DeFronzo RA.

    Diabetes Care. 2006 Oct;29(10):2275-81.PMID: 17003306 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms.

    Fernandez M, Triplitt C, Wajcberg E, Sriwijilkamol AA, Musi N, Cusi K, DeFronzo R, Cersosimo E.

    Diabetes Care. 2008 Jan;31(1):121-7. Epub 2007 Oct 1.PMID: 17909084 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.

    Torlone E, Britta M, Rambotti AM, Perriello G, Santeusanio F, Brunetti P, Bolli GB.

    Diabetes Care. 1993 Oct;16(10):1347-55.PMID: 8269792 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes.

    Launay B, Zinman B, Tildesley HD, Strack T, Chiasson JL.

    Diabetes Care. 1998 Oct;21(10):1627-31.PMID: 9773721 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity